We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Update on Rare Blood Disease Patients Undergoing Gene Therapy Clinical Trial

News   Jan 29, 2020 | Original story from the Broad Stem Cell Research Center

 
Update on Rare Blood Disease Patients Undergoing Gene Therapy Clinical Trial

At left, image shows white blood cells (red) from one of the X-CGD clinical trial participants before gene therapy. At right, after gene therapy, white blood cells from the same patient show the presence of the chemicals (blue) needed to attack and destroy bacteria and fungus. Credit: UCLA Broad Stem Cell Research Center/Nature Medicine

 
 
 

RELATED ARTICLES

Research Outlines How Drug in Clinical Trial for Coronavirus Works

News

A new study published in the Journal of Biological Chemistry outlines how an antiviral drug that is currently being tested in patients with the novel coronavirus (COVID-19), remdesivir, works.

READ MORE

Clinical Trial Results: Immune Therapy Reduces Risk of Aggressive Breast Cancer Recurrence

News

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Queen Mary University of London.

READ MORE

Diabetes in Mice Cured Rapidly Using Human Stem Cell Strategy

News

After converting human stem cells into insulin-producing cells, researchers have demonstrated in mice infused with such cells that diabetes can be functionally cured for nine months.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE